BioSpace News Archive

The Guardian of Excellence Award recognizes top-performing health care organizations that have achieved the 95th percentile or above of performance in Patient Experience.

Technavio has been monitoring the global nephrology and urology devices market and the market is poised to grow by USD 6 billion during 2019-2023 at a CAGR of more than 5% during the forecast period.

NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced the closing of its public offering of 4,077,192 shares of its common stock at a public offering price of $36.75 per share.

TRS is a novel drug for the treatment of blinding ocular diseases

Dr. Paul Woodard joins Immune-Onc from Bellicum Pharmaceuticals, Inc. where he most recently served as Senior Vice President, Clinical and Medical Affairs.

Positive Clinical Trial Results Published

FemmePharma CEO recognized for commitment to improving quality of life for women.

Dr. Goy received the award at the 37th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow meeting

Technavio has announced its latest market research report titled global multiple sclerosis drugs market 2019-2023.

National Consumers League Launches New Initiative to Warn Consumers about Known and Unknown Risks Related to Unregulated CBD Products